Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability

Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability

Bibliographic Details
Main Authors: Brändstedt, Jenny, Wangefjord, Sakarias, Nodin, Björn, Eberhard, Jakob, Jirström, Karin, Manjer, Jonas
Format: Online
Language:English
Published: BioMed Central 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041054/
id pubmed-4041054
recordtype oai_dc
spelling pubmed-40410542014-06-03 Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability Brändstedt, Jenny Wangefjord, Sakarias Nodin, Björn Eberhard, Jakob Jirström, Karin Manjer, Jonas Research Article BioMed Central 2014-05-25 /pmc/articles/PMC4041054/ /pubmed/24885829 http://dx.doi.org/10.1186/1471-2407-14-371 Text en Copyright © 2014 Brändstedt et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Brändstedt, Jenny
Wangefjord, Sakarias
Nodin, Björn
Eberhard, Jakob
Jirström, Karin
Manjer, Jonas
spellingShingle Brändstedt, Jenny
Wangefjord, Sakarias
Nodin, Björn
Eberhard, Jakob
Jirström, Karin
Manjer, Jonas
Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability
author_facet Brändstedt, Jenny
Wangefjord, Sakarias
Nodin, Björn
Eberhard, Jakob
Jirström, Karin
Manjer, Jonas
author_sort Brändstedt, Jenny
title Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability
title_short Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability
title_full Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability
title_fullStr Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability
title_full_unstemmed Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability
title_sort associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin d1, p53, and microsatellite-instability
description
publisher BioMed Central
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041054/
_version_ 1612095235364487168

Similar Items